Kiran Avancha

Kiran Avancha, PhD, currently serves as the Chief Innovation Officer at HonorHealth, a position held since October 2015, where responsibilities include developing innovation strategies and managing the innovation process from ideation to delivery. Additionally, Kiran Avancha is the Chief Operating Officer of the HonorHealth Research Institute and co-founder and CEO of PriZm Tx since August 2020. Previous roles include serving on the Board of Directors for CenSyn, Inc., acting as a seed investor for Chronus Health, and co-founding ClinSync Clinical Research in India. Prior experience also encompasses roles as Director of Cancer Clinical Research at Hartford HealthCare and Lead Clinical Research Pharmacist at the University of Miami. Kiran Avancha's educational background includes a Ph.D. in Medicinal/Pharmaceutical Chemistry from the University of South Florida and a B.Pharm from Osmania University.